Expertise in
27
conditions

Dr. Jeffrey S. Heier

Ophthalmology
Ophthalmic Consultants Of Boston Inc
50 Staniford St Ste 600, 
Boston, MA 
Accepting New Patients
Expertise in
27
conditions
Ophthalmic Consultants Of Boston Inc
50 Staniford St Ste 600, 
Boston, MA 

Overview

Jeffrey Heier is an Ophthalmologist practicing medicine in Boston, Massachusetts.

Dr. Heier is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Retinal Vein Occlusion, and Vitrectomy.

He is actively involved in clinical research, co-authoring 139 peer reviewed articles and participating in 6 clinical trials. Dr. Heier is currently accepting new patients.

Specialties

Ophthalmology

Licenses

Ophthalmology in MA

Hospital Affiliations

Massachusetts Eye And Ear Infirmary -

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Ophthalmic Consultants of Boston Inc
50 Staniford St Ste 600, Boston, MA 02114
Other Locations
Cape Cod Eye Surgery and Laser Center
282 Route 130, Sandwich, MA 02563

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 1, Open-Label, Multi-Center, Dose-Escalating, Safety and Tolerability Study of a Single Intravitreal Injection of AAVCAGsCD59 in Patients With Advanced Non-Exudative (Dry) Age-Related Macular Degeneration With Geographic Atrophy
A Phase 1, Open-Label, Multi-Center, Dose-Escalating, Safety and Tolerability Study of a Single Intravitreal Injection of AAVCAGsCD59 in Patients With Advanced Non-Exudative (Dry) Age-Related Macular Degeneration With Geographic Atrophy
Enrollment Status: Completed
Publish Date: March 30, 2025
Intervention Type: Biological
Study Phase: Phase 1
A Phase 1 Proof of Concept Study Evaluating Intravitreal AAVCAGsCD59 for the Treatment of Wet Age-Related Macular Degeneration (AMD)
A Phase 1 Proof of Concept Study Evaluating Intravitreal AAVCAGsCD59 for the Treatment of Wet Age-Related Macular Degeneration (AMD)
Enrollment Status: Completed
Publish Date: March 30, 2025
Intervention Type: Biological, Drug
Study Drugs: Intravitreal Anti-VEGF, Intravitreal AAVCAGsCD59, Oral Prednisolone
Study Phase: Phase 1
TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
Enrollment Status: Completed
Publish Date: December 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.
Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.
Enrollment Status: Completed
Publish Date: November 29, 2021
An Exploratory, Multi-Center, Randomized, Single-Masked Study Evaluating the Effect of KPI-121 on Intraretinal or Subretinal Fluid Secondary to Retinal Vein Occlusion or Diabetic Macular Edema
An Exploratory, Multi-Center, Randomized, Single-Masked Study Evaluating the Effect of KPI-121 on Intraretinal or Subretinal Fluid Secondary to Retinal Vein Occlusion or Diabetic Macular Edema
Enrollment Status: Completed
Publish Date: December 10, 2020
Intervention Type: Drug
Study Phase: Not Applicable
Short-Term Oral Mifepristone for Central Serous Chorioretinopathy. A Placebo-controlled Dose Ranging Study of Mifepristone in the Treatment of CSC (STOMP-CSC)
Short-Term Oral Mifepristone for Central Serous Chorioretinopathy. A Placebo-controlled Dose Ranging Study of Mifepristone in the Treatment of CSC (STOMP-CSC)
Enrollment Status: Completed
Publish Date: July 26, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

139 Total Publications

Real-world durability challenges with nAMD treatments and the potential promise of gene therapy.
Real-world durability challenges with nAMD treatments and the potential promise of gene therapy.
Journal: Current medical research and opinion
Published: May 14, 2026
Similar Doctors
Expertise in
19
conditions
Dr. Eric A. Pierce
Ophthalmology
Expertise in
19
conditions
Dr. Eric A. Pierce
Ophthalmology
Referral may be required

Massachusetts Eye And Ear

243 Charles St, 
Boston, MA 
 (0.3 miles away)
617-573-3621
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Eric Pierce is an Ophthalmologist practicing medicine in Boston, Massachusetts. Dr. Pierce is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Retinopathy Pigmentary Mental Retardation, Retinitis Pigmentosa, Doyne Honeycomb Retinal Dystrophy, and Late-Onset Retinal Degeneration. Dr. Pierce is currently accepting new patients.

Expertise in
27
conditions
Dr. John B. Miller
Ophthalmology
Expertise in
27
conditions
Dr. John B. Miller
Ophthalmology
Referral may be required
Before you request

Mass Eye And Ear, Ophthalmology

243 Charles Street, 
Boston, MA 
 (0.3 miles away)
617-573-3750
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Miller is an Ophthalmologist practicing medicine in Boston, Massachusetts. Dr. Miller is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, and Vitrectomy. Dr. Miller is board certified in Ophthalmology. Dr. Miller is currently accepting new patients.

Expertise in
27
conditions
Expertise in
27
conditions
Referral may be required

Massachusetts Eye And Ear

243 Charles St, 
Boston, MA 
 (0.3 miles away)
617-573-6874
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Demetrios Vavvas is an Ophthalmologist practicing medicine in Boston, Massachusetts. Dr. Vavvas is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal. Dr. Vavvas is currently accepting new patients.

Frequently Asked Questions about Dr. Jeffrey S. Heier

How do I make an appointment with Dr. Jeffrey S. Heier?

You can book an appointment with Dr. Jeffrey S. Heier by calling their office at 617-367-4800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jeffrey S. Heier a top-rated expert for Age-Related Macular Degeneration (ARMD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey S. Heier is classified as an Elite expert for Age-Related Macular Degeneration (ARMD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jeffrey S. Heier specialize in?

While Dr. Jeffrey S. Heier is a Ophthalmology, they have specific expertise in Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Geographic Atrophy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.

Does Dr. Jeffrey S. Heier participate in research or clinical trials?

Yes. Dr. Jeffrey S. Heier has published 139 articles and abstracts on conditions like Age-Related Macular Degeneration (ARMD). You can view a list of Dr. Jeffrey S. Heier's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jeffrey S. Heier accept my insurance?

Dr. Jeffrey S. Heier accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-367-4800 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Heier's expertise for a condition
ConditionClose
View All 16 Advanced Conditions
View All 27 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile